| Literature DB >> 28409544 |
Markus Polke1, Frederik Seiler1, Philipp M Lepper1, Andreas Kamyschnikow1, Frank Langer2, Dominik Monz3, Christian Herr1, Robert Bals1, Christoph Beisswenger1.
Abstract
Chronic diseases of the respiratory tract, such as cystic fibrosis, are associated with mucosal and systemic hypoxia. Innate immune functions of airway epithelial cells are required to prevent and control infections of the lung parenchyma. The transcription factor hypoxia-inducible factor 1α (HIF-1α) regulates cellular adaptation to low oxygen conditions. Here, we show that hypoxia and HIF-1α regulate innate immune mechanisms of cultured human bronchial epithelial cells (HBECs). Exposure of primary HBECs to hypoxia or the prolyl hydroxylase inhibitor dimethyloxaloylglycine (DMOG) resulted in a significantly decreased expression of inflammatory mediators (IL-6, IFN-γ-induced protein 10) in response to ligands for TLRs (flagellin, polyI:C) and Pseudomonas aeruginosa, whereas the expression of inflammatory mediators was not affected by hypoxia or DMOG in the absence of microbial factors. Small interfering RNA-mediated knockdown of HIF-1α in HBECs and in the bronchial epithelial cell line Calu-3 resulted in increased expression of inflammatory mediators. The inflammatory response was decreased in lungs of mice stimulated with inactivated P. aeruginosa under hypoxia. These data suggest that hypoxia suppresses the innate immune response of airway epithelial cells via HIF-1α.Entities:
Keywords: HIF-1; Hypoxia; airway epithelial cell; infection; innate immunity; respiratory diseases
Mesh:
Substances:
Year: 2017 PMID: 28409544 DOI: 10.1177/1753425917698032
Source DB: PubMed Journal: Innate Immun ISSN: 1753-4259 Impact factor: 2.680